HomeHealthcare & Life SciencesBiotechnology Warfarin Sensitivity Test Market

South Korea Warfarin Sensitivity Test Market Size & Outlook, 2026-2034


South Korea Warfarin Sensitivity Test Market Insights

  • Based on Reed Intelligence findings, the South Korea Warfarin Sensitivity Test Market reached USD 21.16 Million in 2025 and is estimated to attain USD 42.91 Million by 2034.
  • From 2026 to 2034, the South Korea market is expected to grow at a steady CAGR of 8.18%.
  • Within the Test Type category, Genetic Sensitivity Tests dominated in 2025 in terms of market size contribution.
  • Over the forecast period, Point-of-Care Rapid Tests is forecasted to deliver the fastest growth, positioning it as the most lucrative Test Type segment.

Other Key Findings


  • In 2025, South Korea represented 1.79% of the overall global Warfarin Sensitivity Test Market size.
  • United States is projected to lead the global Warfarin Sensitivity Test Market size by 2034.
  • Across Asia Pacific, China is anticipated to hold the dominant position in market size by 2034.
  • India is forecasted to expand at the fastest pace in Asia Pacific, attaining USD 161.21 Million by 2034.

Report Summary

Report Scope Details
Base Year for Study 2025
Study Period 2022-2034
Historical Period 2022-2024
Forecast Period 2026-2034
Market Size In 2025 USD 21.16 Million
Market Size In 2034 USD 42.91 Million
Largest segment Genetic Sensitivity Tests
Units Revenue in USD Million
CAGR 8.18% (2026-2034)
Segmnetation Covered
Test Type
  1. Genetic Sensitivity Tests
  2. Functional Response Tests
  3. Point-of-Care Rapid Tests
End Use
  1. Hospitals
  2. Diagnostic Laboratories
  3. Specialty Clinics
  4. Research Institutes
Technology
  1. PCR-Based Assays
  2. Microarray Platforms
  3. NGS-Based Panels
  4. Others
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Related Reports